While there is broad agreement about the need to improve the design and conduct of clinical trials, 10 pharmaceutical companies are trying to do something about it. The resulting collaboration - TransCelerate BioPharma Inc. - is tackling five areas of clinical trials that actually are tractable in the short term.

The not-for-profit isn't disclosing many metrics, including funding, but does expect to meet important milestones on the projects within a year.